Latest Articles
Endometriosis - Your Body Uncovered With Kate Garraway Vancouver News (ZRMRYavBfP) - Mshale
Endometriosis - Your Body Uncovered With Kate Garraway Vancouver News (ZRMRYavBfP) Mshale
Published: Aug. 9, 2026, 12:33 a.m.
Endometrial carcinosarcoma with multi-classifier molecular signature (MMRd-p53abn): A case report - EurekAlert!
Endometrial carcinosarcoma with multi-classifier molecular signature (MMRd-p53abn): A case report EurekAlert!
Published: Aug. 4, 2026, 7:14 p.m.
Endometrial carcinosarcoma with multi-classifier molecular signature (MMRd-p53abn): A case report - eurekalert.org
Endometrial carcinosarcoma with multi-classifier molecular signature (MMRd-p53abn): A case report eurekalert.org
Published: Aug. 4, 2026, 7:14 p.m.
Pembrolizumab Monotherapy Beats Chemotherapy in Front-Line dMMR Endometrial Cancer - Clinical Oncology News
Pembrolizumab Monotherapy Beats Chemotherapy in Front-Line dMMR Endometrial Cancer Clinical Oncology News
Published: Aug. 3, 2026, 3:32 p.m.
Pembrolizumab Monotherapy Beats Chemotherapy in Front-Line dMMR Endometrial Cancer - clinicaloncology.com
Pembrolizumab Monotherapy Beats Chemotherapy in Front-Line dMMR Endometrial Cancer clinicaloncology.com
Published: Aug. 3, 2026, 3:31 p.m.
Merck (MRK) Says KEYTRUDA Beat Chemotherapy In Phase 3 Endometrial Cancer Trial - Yahoo Finance
Merck (MRK) Says KEYTRUDA Beat Chemotherapy In Phase 3 Endometrial Cancer Trial Yahoo Finance
Published: July 27, 2026, 10:08 p.m.
Psychology graduate’s research highlights impact of long waits for endometriosis diagnosis - Nation.Cymru
Psychology graduate’s research highlights impact of long waits for endometriosis diagnosis Nation.Cymru
Published: July 17, 2026, 6:45 a.m.
Giuseppe Caruso: KEYTRUDA Improves Progression-Free Survival in Frontline dMMR Endometrial Cancer - Oncodaily
Giuseppe Caruso: KEYTRUDA Improves Progression-Free Survival in Frontline dMMR Endometrial Cancer Oncodaily
Published: July 16, 2026, 4:40 p.m.
Pembrolizumab Monotherapy Improves PFS in Frontline dMMR Endometrial Cancer - CancerNetwork
Pembrolizumab Monotherapy Improves PFS in Frontline dMMR Endometrial Cancer CancerNetwork
Published: July 16, 2026, 3:40 p.m.
Merck's (MRK) Keytruda Becomes First PD-1 Inhibitor To Beat Chemotherapy Alone In Endometrial Cancer Subtype - londoninsider.co.uk
Merck's (MRK) Keytruda Becomes First PD-1 Inhibitor To Beat Chemotherapy Alone In Endometrial Cancer Subtype londoninsider.co.uk
Published: July 15, 2026, 11:49 p.m.
Link copied to clipboard!